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Abstract
The aim of this study was to compare the value of superb microvascular imaging (SMI) in carpal tunnel syndrome (CTS) with that of
color Doppler ultrasonography (CDUS) and power Doppler ultrasonography (PDUS).
Fifty patients with symptomatic CTS and 25 healthy volunteers were enrolled. The cross-sectional area (CSA), CDUS score, PDUS
score, and SMI score of the median nerve (MN) at the carpal tunnel were recorded. The value of different ultrasonography (US)
diagnostic strategies was calculated.
The blood ﬂow display ratio in the MN of the healthy volunteers had no statistical difference between CDUS, PDUS, and SMI (20%,
32%, and 48%, respectively, P>.05). The blood ﬂow display ratio for SMI in patients was signiﬁcantly higher than that of CDUS and
PDUS (90%, 52%, and 60%, respectively, P<.005). The accuracy of SMI score ≥2 (79%) was much higher than that of CDUS and
PDUS (61% and 63%, respectively, P<.05). Comprehensive consideration of SMI and CSA, CSA≥10.5mm2, and/or SMI score ≥2
has the highest accuracy (83%), signiﬁcantly higher than that of CSA combination with CDUS or PDUS (68% and 69%, respectively,
P<.05).
SMI is more sensitive to display the blood ﬂow in the MN with CTS than CDUS and PDUS. It might signiﬁcantly improve the
diagnosis value for CTS.
Abbreviations: BMI = body mass index, CDUS = color Doppler US, CSA = cross-sectional area, CTS = carpal tunnel syndrome,
EDT = electrodiagnostic testing, LR = likelihood ratio, MN = median nerve, PDUS = power Doppler US, ROC = receiver operating
characteristic, SMI = superb microvascular imaging, US = ultrasonography.
Keywords: carpal tunnel syndrome, median nerve, musculoskeletal, peripheral neuropathies, ultrasonography
1. Introduction
Carpal tunnel syndrome (CTS) is a common peripheral
entrapment neuropathy, that is, the median nerve (MN) is
pressured at the carpal tunnel which causes symptom related to
nerve damage.[1,2] The diagnosis of CTS relies on symptom,
physical sign and electrodiagnostic testing (EDT).[3] However,
some diseases, such as polyneuropathy and cervical radiculop-
athy, can also have similar clinical performance.[4–6] Physical
examinations, Tinel testing and Phalen testing for example, lack
objective judgment criterion. EDT can provide objective
diagnosis basis, which has very high speciﬁcity. However, it will
cause 10% to 25% false negative, especially for early CTS.[7,8]
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Furthermore, some people refuse or couldn’t tolerate it because of
its invasive nature.
High-frequency grey scale ultrasonography (US) can clearly
show the MN and surrounding structures, which provides
valuable information for clinical treatment. Generally, an
increased nerve cross-sectional area (CSA) is the main objective
criterion for diagnosis CTS on US. However, the cut-off value for
CSA differs from 8.5 to 15mm2 in different studies.[9–12] The
uncertainty of the diagnosis criterion affects its value. In addition,
research found that the sensitivity was low for diagnosis replying
on CSA alone.[13] Some other criterions derived from CSA, such
as the difference or ratio of MN at wrist and forearm showing
higher sensitivities, were described only in few researches[14,15]
and haven’t been used in clinical practice.
The MN is provided by a rich anastomotic system of epineural
and endoneural blood vessels, which extends vertically from
epineuria to fascicular.[16] An animal model of entrapment
neuropathy has shown an increased production of vascular
endothelial growth factor, which indicates the increasing of
intranerval microvascular density.[17] Some researchers evaluated
the accuracy of color Doppler US (CDUS) and power Doppler US
(PDUS) in the diagnosis of CTS, but came to different and even
contradictory results.[13,18–20] The patients enrolled in these
studies had different characteristics may be partially responsible
for the disagreement. However, the more important reason may
be that these Doppler technologies have low sensitivity for the
blood ﬂow. Therefore, they cannot show small, low speed blood
ﬂow signals.[21] Contrast-enhanced ultrasound can improve the
display effect, but ultrasound contrast agents need injecting.
Presently, there is only 1 study about contrast-enhanced
ultrasound of the MN on Macaca fascicularis,[22] human study
has not yet been reported.
Superb microvascular imaging (SMI) is a latest ultrasound
technology to display blood ﬂow signals in real time, developed by
Toshiba. It uses self-adaptive algorithm and can differentiate low-
speed blood ﬂow signal and tissue motion artifact. Comparing to
traditional Doppler technique, SMI was reported to have higher
sensitivity for blood ﬂow than CDUS and PDUS in some small
organs.[23–26] But, to the best of our knowledge, the value of SMI in
detecting intranerval blood ﬂow has not yet been investigated. The
purpose of this research is to evaluate the appearance of SMI of the
MN in healthy volunteers and patients with CTS and to compare
the diagnostic value of SMI with CDUS and PDUS.
2. Materials and methods
This research was approved by the hospital ethics committee and
written consent was obtained from all participants.
All subjects were examined in the sitting position with their
hands in a supine position and ﬁngers semiextended. We used an
Aplio 500 ultrasound machine (Toshiba, Tokyo, Japan) with an
18MHz linear-array probe. Continuous transverse and longitu-
dinal scan for the MN was performed. We applied the model of
musculoskeletal. In the grayscale mode, frame rate: 6, aplipure: 5,
precision: 3, frequency: diff T18.0. Focus was set at the level of
the MN. Gray gain was adjusted to 80 to 90 to optimize the
image brightness. CSA of the MN was determined by tracing a
continuous line including the epineurium on a transverse scan at
the distal wrist crease, that is, proximal to the retinaculum, where
was usually the most swollen part of theMN in CTS. The average
value of the results of 3 times was adopted.
Then we performed CDUS, PDUS, and SMI. We adjusted the
pulse repetition frequency (PRF) to a low level for the detection of
low-ﬂow vessels, usually the number at the upper left corner of
the image was displayed as 4.7 (in CDUS and PDUS modes) and
1.9 (in SMI mode). In the CDUS and PDUS mode, the PRF
couldn’t be adjusted as low as in SMI model, otherwise there
would be an artifact from the organization movement caused by
arterial pulsation. This experience has been obtained in previous
work. The color gain was adjusted to the maximum level, usually
from 35 to 45, which did not produce clutter or noisy artifact.
We evaluated a blood ﬂow score from 0 to 3, according to the
richness of the blood ﬂow signal within the MN in a longitudinal
scan. Figure 1 shows the detailed criterion in SMI: 0 score, no
blood ﬂow; 1 score, 1 to 2 spot blood ﬂow; 2 score, more than 2
spot blood ﬂow or 1 to 2 strip blood ﬂow (longer than 1mm); and
3 score, more than 2 strip blood ﬂow. The scoring criteria of the
CDUS, PDUS, and SMI modes were the same. Each wrist US
examination lasted about 6 minutes.
We conducted a preliminary study of 20 clinically diagnosed
CTS patients to evaluate the interobserver reliability for the blood
ﬂow score between 2 radiologists. Observer A (JC) and observer
B (LC) had 5 and 2 years of experience in musculoskeletal
ultrasound, respectively. All the patients had the characteristic
clinical symptoms, such as numbness for median nerve dominant
ﬁnger and emission pain. Positive results for Tinel or Phalen
testing and EDT increased the diagnostic performance. EDT
diagnostic criteria in our hospital were as follows: motor latencies
>4.0 ms, amplitudes <6.3 uv, sensory latencies >3.5 ms,
amplitudes <20.0 uv, and motor conduction velocity <55 m/s.
Patients withmetabolic disease such as diabetes and chronic renal
failure, a history of wrist trauma, rheumatism, a biﬁd median
nerve or persistent median artery, a history of previous wrist
surgery, and any symptoms of cervical radiculopathy were
excluded.
Then the clinical research including patient group and control
group was performed prospectively in our institution. Inclusion
and exclusion criteria for the patient group were the same as the
preliminary study. The control group was made up of
asymptomatic healthy volunteers. All US examinations were
performed by radiologist (JC) between October 2015 and
February 2016. Time interval between US and EDT was 2 to
7 days (mean 4 days) without any treatment. There was no any
adverse event from our experiment.
Totally, there were consecutive 79 participants in the clinical
research. Some studies suggested that anatomical variations
may be prone to CTS,[27,28] so, 3 patients with biﬁd median
nerve and 1 healthy volunteer with persistent median artery
were excluded from the statistics (Fig. 2). There were 50
cases in the patient group. One symptomatic wrist was
observed in each case. If both sides had symptom, the more
severe side was observed. If both sides had similar severity,
dominant side was observed. In the control group, 25 dominant
hands were observed. The radiologist was blinded to the
medical history of the participants.
2.1. Statistical analysis
Statistical analysis was performed using SPSS software (version
18.0, SPSS Inc. Chicago, IL). Differences were analyzed using
the Student t-test, and x2 test. P<.05 was considered to
indicate a signiﬁcant difference. Interobserver agreement of
blood ﬂow score for each sonographic technique was assessed
using kappa statistics. The receiver operating characteristic
(ROC) curve was used to determine the cutoff value for the
CSA of MN. The sensitivity, speciﬁcity, likelihood ratio (LR),
Chen et al. Medicine (2017) 96:21 Medicine
2
and accuracy have been calculated with 95% conﬁdence
interval (CI).
3. Results
The interobserver reliability was estimated according to the
preliminary study, and the results showed a good level of
agreement. Kappa coefﬁcients for CDUS, PDUS, and SMI were
0.779, 0.716, and 0.846, respectively.
The common clinical data of the participants are shown in
Table 1. There were no signiﬁcant different for age, sex, and body
Figure 2. Flowchart of participants selection.
Figure 1. SMI score for the MN. (A) 0 score, no blood ﬂow detected within MN; (B) 1 score, 2 spot blood ﬂow within MN; (C) 2 score, more than 2 spot blood ﬂow
within MN; (D) 3 score, more than 2 strip blood ﬂow within MN. MN = median nerve, SMI = superb microvascular imaging.
Table 1
Clinical characteristics of patient group and control group.
Variable
Patient
(n=50)
Control
(n=25)
Age, y
∗,† 55.4±15.6 53.6±15.1
Sex
Female
∗,† 41 (82.0%) 20 (80.0%)
BMI
∗,† 22.6±3.5 21.8±3.1
Symptom duration, months
∗
8.2±5.7
CSA, mm2, of the MN at the distal wrist crease
∗,‡ 12.16±3.09 9.16±2.15
CDUS score
0 24 20
1 22 5
2 3 0
3 1 0
PDUS score
0 20 17
1 24 8
2 4 0
3 2 0
SMI score
0 5 13
1 10 11
2 24 1
3 11 0
BMI=body mass index, CDUS= color Doppler ultrasonography, CSA= cross-sectional area, MN=
median nerve, PDUS=power Doppler ultrasonography, SMI= superb microvascular imaging.
∗
Data are means± standard deviations.
† P>.05.
‡ P<.001.
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mass index (BMI) between patient group and control group. The
CSA of theMN at the distal wrist crease was signiﬁcantly larger in
patient group than that of control group (mean12.16mm2vsmean
9.16mm2, P<.001).
In patient group, the blood ﬂow display ratio of CDUS (26/50,
52%) in the MN was not signiﬁcantly different when compared
to that of PDUS (30/50, 60%). The blood ﬂow display ratio of
SMI (45/50, 90%) was signiﬁcantly higher than that of CDUS
and PDUS (P<.005) (Fig. 3). In control group, the blood ﬂow
display ratio of CDUS, PDUS, and SMI were 20%, 32%, and
48%, respectively, without statistical signiﬁcance (P>.05).
Figure 4 shows the ROC curve of the MN’s CSA at the distal
wrist crease. The cut-off value of the CSA was 10.5 mm2 with a
sensitivity of 64%, a speciﬁcity of 76%, and an area under the
ROC curve of 0.78 (95% CI: 0.68 to 0.89).
The positive rate of different US diagnostic criteria in patient
group and control group is shown in Table 2. The sensitivity,
speciﬁcity, LR, and accuracy of different US diagnostic criteria
for CTS are shown in Table 3.
If SMI≥3orCDUS/PDUS≥2/3were considered as the diagnostic
criteria, the sensitivity and accuracy were low, varying 0.02 to 0.22
and 0.35 to 0.48, respectively. Of all the other US diagnostic
strategies, CSA ≥10.5mm2 and/or SMI ≥1 and SMI ≥1 had the
highest sensitivity (98% and 90%, respectively). SMI ≥2 had the
highest speciﬁcity (96%). While CSA ≥10.5mm2 and/or SMI ≥2
andCSA≥10.5mm2 and/or SMI≥1had the highest accuracy (83%
and 81%, respectively). The accuracy of SMI score ≥1 and SMI
score ≥2 (77% and 79%, respectively) was higher than the highest
accuracy of CDUS and PDUS (61% and 63%, P<.05). The
accuracy of CSA ≥10.5mm2 and/or SMI score ≥1 and CSA ≥10.5
Figure 3. Ultrasound images of the MN at the same level from a 65-year-old female CTS patient, which shows score 1 by CDUS, score 2 by PDUS, and score 3 by
SMI. CDUS = color Doppler ultrasonography, CTS = carpal tunnel syndrome, PDUS = power Doppler ultrasonography, SMI = superb microvascular imaging.
Figure 4. ROC curve of CSA at the distal wrist crease. CSA = cross-sectional
area, ROC = receiver operating characteristic.
Chen et al. Medicine (2017) 96:21 Medicine
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mm2 and/or SMI score≥2 (81%and 83%, respectively) was higher
than the highest accuracy of CSA ≥10.5mm2 combination with
CDUSorPDUS (68%and69%, respectively,P<.05). The accuracy
of CSA ≥10.5mm2 and/or SMI ≥3 (68%) was not signiﬁcantly
higher than that ofCSA≥10.5mm2combiningwithCDUSorPDUS
(68% and 69%, respectively, P>.05).
4. Discussion
The diagnosis of CTS mainly relies on clinic symptoms and EDT.
Due to the lack of speciﬁcity of symptoms and 10% to 25% false
negative rate of EDT,[7,8] the quality stands Subcommittee of the
American Academy of Neurology has recommended using US as
one of the diagnosis tools since 1990s.[29] The increasement of the
MN’s CSA is the classic standard of gray US. This is caused by an
increase in the pressure of the nerve which causes venous
congestion and a limited axoplasm ﬂow of the nerve. Prior studies
have shown that the CSA’s cut-off value varies a lot. The common
cut-off value was 10 to 11mm2 with a sensitivity of 57% to 97%
and speciﬁcity of 65% to 97%,[11,30–33] In our study, the CSA
cut-off value was 10.5mm2, the sensitivity was 64%, and the
speciﬁcity was 76%, which was similar to the previous reports.
In addition to grayscale US, Doppler US showed the blood ﬂow
signal in theMN of the CTS increased when compared to healthy
people. The increase of the microvessel density in the MN of CTS
was conﬁrmed by pathology.[17] Schwann cell production of
vascular endothelial growth factor is responsible for the increased
vascularity and Schwann cell proliferation associated with
chronic nerve compression. However, the diagnostic value of
Doppler technique reported in the literatures was not consistent,
which affected the conﬁdence of clinicians. Ghasemi-Esfe et al[20]
reported that color Doppler had the higher diagnosis value with a
sensitivity of 81% and a speciﬁcity of 90%, comparing with CSA
(69% and 94%, respectively). Joy et al’s[13] research suggested
that Doppler had higher sensitivity than CSA, especially for those
patients with unidentiﬁed clinic symptoms, the sensitivity
increased from 30% to 73%. However, Dejaco et al[34] reported
that Doppler’s sensitivity (47.4%) was lower than that of
grayscale US (90.9%). Ultrasound machine has 2 kinds of
Doppler technologies, that is, color Doppler and power Doppler.
Generally, power Doppler is considered to be more sensitive to
display blood ﬂow signals within the tissue. However, to our
knowledge, 2 researches using power Doppler to diagnose CTS
had lower sensitivity comparing to the other 3 researches using
color Doppler (0.48, 0.41 vs 0.80, 0.83, 0.95).[18,20,34–36] The
reasons for the distinction include the difference of inclusion
criteria, severity, judgment criterion of imaging, device, and
Table 2
Positive rate of different US diagnostic criteria in patient group (n=
50) and control group (n=25).
Patient n (%) Control n (%) P value
CSA ≥10.5 mm2 32 (64) 6 (24) .001
CDUS score ≥1 26 (52) 5 (20) .008
CDUS score ≥2 4 (8) 0 (0) .29
CDUS score ≥3 1 (2) 0 (0) 1.00
PDUS score ≥1 30 (60) 8 (32) .022
PDUS score ≥2 6 (12) 0 (0) .17
PDUS score ≥3 2 (4) 0 (0) .55
SMI score ≥1 45 (90) 12 (48) .00006
SMI score ≥2 35 (70) 1 (4) .00000
SMI score ≥3 11 (22) 0 (0) .013
CSA≥10.5 mm2 and/or CDUS score ≥1 35 (70) 9 (36) .005
CSA≥10.5 mm2 and/or CDUS score ≥2 32 (64) 6 (24) .001
CSA≥10.5 mm2 and/or CDUS score ≥3 32 (64) 6 (24) .001
CSA≥10.5 mm2 and/or PDUS score ≥1 38 (76) 12 (48) .015
CSA≥10.5 mm2 and/or PDUS score ≥2 33 (66) 6 (24) .001
CSA≥10.5 mm2 and/or PDUS score ≥3 32 (64) 6 (24) .001
CSA≥10.5 mm2 and/or SMI score ≥1 49 (98) 13 (52) .00000
CSA≥10.5 mm2 and/or SMI score ≥2 43 (86) 6 (24) .00000
CSA≥10.5 mm2 and/or SMI score ≥3 32 (64) 6 (24) .001
CDUS= color Doppler US, CSA=cross-sectional area, PDUS=power Doppler US, SMI= superb
microvascular imaging, US = ultrasonography.
Table 3
Sensitivity, speciﬁcity, LR, and accuracy of different US diagnostic criteria for CTS.
Sensitivity (95% CI) Speciﬁcity (95% CI) LR positive (95% CI) LR negative (95% CI) Accuracy (95% CI)
CSA ≥10.5 mm2 0.64 (0.49–0.77) 0.76 (0.55–0.91) 2.67 (1.29–5.52) 0.47 (0.31–0.73) 0.68 (0.56–0.78)
CDUS score ≥1 0.52 (0.37–0.66) 0.80 (0.59–0.93) 2.60 (1.14–5.95) 0.60 (0.42–0.85) 0.61 (0.49–0.72)
CDUS score ≥2 0.08 (0.02–0.19) 1.00 (0.80–1.0) Inf (NaN-Inf) 0.92 (0.85–1.00) 0.39 (0.28–0.51)
CDUS score ≥3 0.02 (0.001–0.11) 1.00 (0.80–1.0) Inf (NaN-Inf) 0.98 (0.94–1.02) 0.35 (0.24–0.47)
PDUS score ≥1 0.60 (0.45–0.74) 0.68 (0.47–0.85) 1.88 (1.01–3.47) 0.59 (0.38–0.91) 0.63 (0.51–0.74)
PDUS score ≥2 0.12 (0.05–0.24) 1.00 (0.80–1.00) Inf (NaN-Inf) 0.88 (0.79–0.98) 0.41 (0.30–0.53)
PDUS score ≥3 0.04 (0.01–0.14) 1.00 (0.80–1.0) Inf (NaN-Inf) 0.96 (0.91–1.02) 0.36 (0.25–0.48)
SMI score ≥1 0.90 (0.78–0.97) 0.52 (0.31–0.72) 1.88 (1.23–2.85) 0.19 (0.08–0.48) 0.77 (0.66–0.86)
∗
SMI score ≥2 0.70 (0.55–0.82) 0.96 (0.80–0.99) 17.50 (2.54–120.44) 0.31 (0.20–0.48) 0.79 (0.68–0.87)
∗
SMI score ≥3 0.22 (0.12–0.36) 1.00 (0.80–1.00) Inf (NaN to Inf) 0.78 (0.67–0.90) 0.48 (0.36–0.60)
CSA≥10.5 mm2 and/or CDUS score ≥1 0.70 (0.55–0.82) 0.64 (0.43–0.82) 1.94 (1.12–3.38) 0.47 (0.28–0.79) 0.68 (0.56–0.78)
CSA≥10.5 mm2 and/or CDUS score ≥2 0.64 (0.49–0.77) 0.76 (0.55–0.91) 2.67 (1.29–5.52) 0.47 (0.31–0.73) 0.68 (0.56–0.78)
CSA≥10.5 mm2 and/or CDUS score ≥3 0.64 (0.49–0.77) 0.76 (0.55–0.91) 2.67 (1.29–5.52) 0.47 (0.31–0.73) 0.68 (0.56–0.78)
CSA≥10.5 mm2 and/or PDUS score ≥1 0.76 (0.62–0.87) 0.52 (0.31–0.72) 1.58 (1.02–2.45) 0.46 (0.25–0.86) 0.68 (0.56–0.78)
CSA≥10.5 mm2 and/or PDUS score ≥2 0.66 (0.51–0.79) 0.76 (0.55–0.91) 2.75 (1.33–5.68) 0.45 (0.29–0.70) 0.69 (0.58–0.80)
CSA≥10.5 mm2 and/or PDUS score ≥3 0.64 (0.49–0.77) 0.76 (0.55–0.91) 2.67 (1.29–5.52) 0.47 (0.31–0.73) 0.68 (0.56–0.78)
CSA≥10.5 mm2 and/or SMI score ≥1 0.98 (0.89–1.00) 0.48 (0.28–0.69) 1.89 (1.29–2.75) 0.04 (0.01–0.30) 0.81 (0.71–0.89)†
CSA ≥10.5mm2 and/or SMI score ≥2 0.86 (0.73–0.94) 0.76 (0.55–0.91) 3.58 (1.77–7.26) 0.18 (0.09–0.38) 0.83 (0.72–0.90)†
CSA ≥10.5mm2 and/or SMI score ≥3 0.64 (0.49–0.77) 0.76 (0.55–0.91) 2.67 (1.29–5.52) 0.47 (0.31–0.73) 0.68 (0.56–0.78)‡
CDUS= color Doppler US, CI= conﬁdence interval, CSA= cross-sectional area, LR= likelihood ratio, PDUS=power Doppler US, SMI= superb microvascular imaging.
∗
P<.05 compared to CDUS score ≥1 and PDUS ≥1.
† P<.05 compared to CSA ≥10.5mm2and/or CDUS score ≥1 and CSA ≥10.5mm2and/or PDUS score ≥1.
‡ P>.05 compared to CSA ≥10.5mm2 combining CDUS or PDUS.
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parameters. Another possibility is that the Doppler technique
itself is insufﬁcient to detect the blood ﬂow in the nerve. One
research showed that the blood ﬂow display ratio was 0% (0/33)
in normal MN.[35] In the study of the correlation between color
Doppler and CTS severity, Mohammadi et al[37] found that the
blood ﬂow display ratio was only 54.4% (49/90) even in CTS
patients. Most experiments also only determined whether there
was blood ﬂow signal in the compressed nerve,[13,18,35,37] only 1
previous research studied power Doppler score in CTS, which got
a sensitivity of 47.4%, using score ≥2 to diagnose CTS.[34] There
was less experience of intranerval blood ﬂow than rheumatoid
synovitis.[38,39] The main reason is that the blood ﬂow of nerve is
more small and slow.
In our control group, the blood ﬂow display ratio of CDUS,
PDUS, and SMI had no statistical difference (P>.05), but with a
trend of increasing (20%, 32%, and 48%, respectively). In
patient group, the blood ﬂow display ratio of SMI was 90%,
higher than that of CDUD and PDUS (52% and 60%,
respectively), with statistical difference (P<.005). CDUS and
PDUS score mainly focused on 0 and 1, only 5 and 8 cases scored
2 and 3, respectively. CDUS or PDUS ≥2 or 3 had low sensitivity,
which was not suitable for diagnosis criterion. SMI signiﬁcantly
increased the results of 2 and 3 score, the SMI score distribution
was more balanced. The accuracies for CDUS ≥1 and PDUS ≥1
were 61% and 63%, respectively, similarly to that of CSA ≥10.5
mm2 (68%). If combining CSA ≥10.5mm2 and CDUS or PDUS
≥1, there was an insigniﬁcant but important increase in sensitivity
(from 64% to 70% or 76%, respectively), even though the
accuracy was not improved.
To thebest ofourknowledge, therewasno report of SMI inCTS.
We analyzed the diagnosis results using different SMI criteria. SMI
score ≥2 achieved the highest accuracy (79%) and gave
consideration to both sensitivity (70%) and speciﬁcity (96%).
At the same time, its positiveLR (=sensitivity/1-speciﬁcity) reached
17.5. SMI score ≥1 had the highest sensitivity (90%) but the
accuracy (77%) was slightly down. SMI score ≥3 had the highest
speciﬁcity (100%), but the sensitivity was too low (22%). Due to
the convenient, noninvasive characteristics of US, SMI score ≥3 is
not suitable as a diagnostic standard for screening tests.[40] If we
combined SMI and CSA, CSA ≥10.5mm2 and/or SMI score ≥2
had the highest accuracy (83%), which was signiﬁcantly higher
than that ofCSA≥10.5mm2and/orCDUS≥1 orCSA≥10.5mm2
and/or PDUS ≥1 (68% and 68%, respectively).
SMI is a new imaging mode to detect blood ﬂow developed by
Toshiba Medical Systems. Employing an advanced Doppler
algorithm with a new level of sensitivity and frame rate for
imaging of the microvasculature, there will be no need for
contrast enhancement. When compared with conventional color
Doppler and power Doppler, the sensitivity and ﬁner detail of the
microvessels can be visualized with SMI appears signiﬁcantly
better. The ability of SMI to scan at high frame rates is important.
The potential clinical value of this advanced technology and how
it could signiﬁcantly change clinical management were illustrated
in several researches.[23–26] In our study, SMI provided improved
results for the evaluation of the blood ﬂow in the MN compared
to the CDUS and PDUS. SMI technology has already been
included in the commercial machine.
Our study had several limitations. First, the intranerval blood
ﬂow distributes in 3 dimensions, but we only analyzed the blood
signal on a longitudinal plane, which didn’t reﬂect the overall
intranerval blood supply. Three-dimensional ultrasound tech-
nology can reveal the complete intranerval blood distribution.
Second, the judgment of SMI score was semiquantitative, even
though good agreement among the observers was also observed,
it still lacked objective data. Using software to analyze the ratio of
color blood pixel can improve this. Third, all patients were
diagnosed by symptoms, physical signs, and EDT results. We
excluded those who had no symptoms, or those mild patients
who had normal EDT results, which may overestimate the
sensitivity in this research. Forth, SMI technology is presently
only installed in some models of Toshiba equipment, not all
ultrasonic instruments have this function. But such instruments
have been commercially available, and the price is similar to that
of conventional instruments.
This is the initial result for SMI in CTS. This technique shows
better display capability for blood ﬂow signal in the MN than
CDUS and PDUS. This indicates that SMImay be a useful tool for
diagnose CTS. However, it still needs more large series of studies.
Further researches are necessary to access the relationship
between richness of blood ﬂow of SMI and length of medical
history, disease severity, and EDT result.
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